121 related articles for article (PubMed ID: 34999039)
41. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
42. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
[TBL] [Abstract][Full Text] [Related]
43. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
[TBL] [Abstract][Full Text] [Related]
44. Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery.
Tanaka K; Kanazawa T; Shibata Y; Suda Y; Fukuda T; Takashima Y; Okada H
Int J Pharm; 2010 Aug; 396(1-2):229-38. PubMed ID: 20600726
[TBL] [Abstract][Full Text] [Related]
45. Biodegradable nanoparticles of methoxy poly(ethylene glycol)-b-poly( d, l-lactide)/methoxy poly(ethylene glycol)- b-poly(ϵ-caprolactone) blends for drug delivery.
Baimark Y; Srisuwan Y
Nanoscale Res Lett; 2012 May; 7(1):271. PubMed ID: 22647275
[TBL] [Abstract][Full Text] [Related]
46. [Preparation of nanoparticles for sustained insulin release using poly (ethylene glycol) -poly (ε-caprolactone)-poly (N, N-diethylamino-2-ethylmethaerylate)].
Wu L; Zhu WT; Wang J; Liu J; Zeng QB
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jul; 37(7):975-982. PubMed ID: 28736379
[TBL] [Abstract][Full Text] [Related]
47. Redox-sensitive micelles assembled from amphiphilic mPEG-PCL-SS-DTX conjugates for the delivery of docetaxel.
Zhang H; Wang K; Zhang P; He W; Song A; Luan Y
Colloids Surf B Biointerfaces; 2016 Jun; 142():89-97. PubMed ID: 26938324
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
49. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
50. Diselenide linkage containing triblock copolymer nanoparticles based on Bi(methoxyl poly(ethylene glycol))-poly(ε-carprolactone): Selective intracellular drug delivery in cancer cells.
Hailemeskel BZ; Hsu WH; Addisu KD; Andrgie AT; Chou HY; Lai JY; Tsai HC
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109803. PubMed ID: 31349440
[TBL] [Abstract][Full Text] [Related]
51. Multifunctional nano-micelles formed by amphiphilic gold-polycaprolactone-methoxy poly(ethylene glycol) (Au-PCL-MPEG) nanoparticles for potential drug delivery applications.
Aryal S; Pilla S; Gong S
J Nanosci Nanotechnol; 2009 Oct; 9(10):5701-8. PubMed ID: 19908441
[TBL] [Abstract][Full Text] [Related]
52. Self-assembled dihydroartemisinin nanoparticles as a platform for cervical cancer chemotherapy.
Lu Y; Wen Q; Luo J; Xiong K; Wu Z; Wang B; Chen Y; Yang B; Fu S
Drug Deliv; 2020 Dec; 27(1):876-887. PubMed ID: 32516033
[TBL] [Abstract][Full Text] [Related]
53. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.
Zoulikha M; Xiao Q; Boafo GF; Sallam MA; Chen Z; He W
Acta Pharm Sin B; 2022 Feb; 12(2):600-620. PubMed ID: 34401226
[TBL] [Abstract][Full Text] [Related]
54. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
[TBL] [Abstract][Full Text] [Related]
55. A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment.
Mei L; Zhang Y; Zheng Y; Tian G; Song C; Yang D; Chen H; Sun H; Tian Y; Liu K; Li Z; Huang L
Nanoscale Res Lett; 2009 Sep; 4(12):1530-9. PubMed ID: 20652101
[TBL] [Abstract][Full Text] [Related]
56. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
57. Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer.
Sharma G; Park J; Sharma AR; Jung JS; Kim H; Chakraborty C; Song DK; Lee SS; Nam JS
Pharm Res; 2015 Feb; 32(2):723-35. PubMed ID: 25186442
[TBL] [Abstract][Full Text] [Related]
58. Chloramphenicol encapsulated in poly-ε-caprolactone-pluronic composite: nanoparticles for treatment of MRSA-infected burn wounds.
Kalita S; Devi B; Kandimalla R; Sharma KK; Sharma A; Kalita K; Kataki AC; Kotoky J
Int J Nanomedicine; 2015; 10():2971-84. PubMed ID: 25931822
[TBL] [Abstract][Full Text] [Related]
59. Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery.
Sun TM; Du JZ; Yan LF; Mao HQ; Wang J
Biomaterials; 2008 Nov; 29(32):4348-55. PubMed ID: 18715636
[TBL] [Abstract][Full Text] [Related]
60. Amphiphilic methoxy poly(ethylene glycol)-b-poly(ε-caprolactone)-b-poly(2-dimethylaminoethyl methacrylate) cationic copolymer nanoparticles as a vector for gene and drug delivery.
Yue X; Qiao Y; Qiao N; Guo S; Xing J; Deng L; Xu J; Dong A
Biomacromolecules; 2010 Sep; 11(9):2306-12. PubMed ID: 20666510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]